ATE261449T1 - Thienopyrimidin verbindungen, ihre herstellung und verwendung - Google Patents

Thienopyrimidin verbindungen, ihre herstellung und verwendung

Info

Publication number
ATE261449T1
ATE261449T1 AT00911308T AT00911308T ATE261449T1 AT E261449 T1 ATE261449 T1 AT E261449T1 AT 00911308 T AT00911308 T AT 00911308T AT 00911308 T AT00911308 T AT 00911308T AT E261449 T1 ATE261449 T1 AT E261449T1
Authority
AT
Austria
Prior art keywords
preparation
thienopyrimidine compounds
thienopyrimidine
compounds
Prior art date
Application number
AT00911308T
Other languages
English (en)
Inventor
Shuichi Furuya
Nobuhiro Suzuki
Nobuo Choh
Yoshi Nara
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE261449T1 publication Critical patent/ATE261449T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT00911308T 1999-03-24 2000-03-23 Thienopyrimidin verbindungen, ihre herstellung und verwendung ATE261449T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7937199 1999-03-24
JP2000018019 2000-01-25
PCT/JP2000/001777 WO2000056739A1 (en) 1999-03-24 2000-03-23 Thienopyrimidine compounds, their production and use

Publications (1)

Publication Number Publication Date
ATE261449T1 true ATE261449T1 (de) 2004-03-15

Family

ID=26420391

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00911308T ATE261449T1 (de) 1999-03-24 2000-03-23 Thienopyrimidin verbindungen, ihre herstellung und verwendung

Country Status (28)

Country Link
US (1) US6340686B1 (de)
EP (1) EP1163244B1 (de)
JP (1) JP3240293B2 (de)
KR (2) KR100533483B1 (de)
CN (1) CN1349536A (de)
AR (1) AR023152A1 (de)
AT (1) ATE261449T1 (de)
AU (1) AU764019B2 (de)
BR (1) BR0009297A (de)
CA (1) CA2368108C (de)
CZ (1) CZ294747B6 (de)
DE (1) DE60008862T2 (de)
DK (1) DK1163244T3 (de)
ES (1) ES2212992T3 (de)
HK (1) HK1042495B (de)
HU (1) HUP0200550A3 (de)
ID (1) ID30393A (de)
IL (1) IL145549A (de)
MX (1) MXPA01009566A (de)
MY (1) MY124726A (de)
NO (1) NO20014603L (de)
NZ (1) NZ514737A (de)
OA (1) OA11920A (de)
PL (1) PL351202A1 (de)
PT (1) PT1163244E (de)
SK (1) SK13552001A3 (de)
TW (1) TWI225863B (de)
WO (1) WO2000056739A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
KR20030005205A (ko) * 2000-02-29 2003-01-17 다케다 야쿠힌 고교 가부시키가이샤 티에노피리미딘 유도체의 제조 방법
US20030134863A1 (en) * 2000-04-13 2003-07-17 Shuichi Furuya Preventives/remedies for alzheimer's disease
EP1291023A1 (de) * 2000-06-14 2003-03-12 Takeda Chemical Industries, Ltd. Formulierungen mit verzögerter wirkstofffreisetzung
AU2001288102A1 (en) * 2000-09-22 2002-04-02 Takeda Chemical Industries Ltd. Solid preparations
WO2002043766A1 (en) * 2000-11-29 2002-06-06 Takeda Chemical Industries, Ltd. Medicinal compositions and process for producing the same
AU2002221139A1 (en) * 2000-12-15 2002-06-24 Takeda Chemical Industries Ltd. Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof
WO2002078669A1 (fr) * 2001-03-30 2002-10-10 Takeda Chemical Industries, Ltd. Solutions medicinales
JP2005500352A (ja) 2001-08-02 2005-01-06 ニューロクライン バイオサイエンシーズ, インコーポレイテッド ゴナドトロピン放出ホルモンレセプター(GnRH)アンタゴニストとしての1,2,4−トリアジン−3,5−ジオン
EP1411941A2 (de) 2001-08-02 2004-04-28 Neurocrine Biosciences, Inc. Pyridinon- und pyridazinonderivate als antagonisten des gonadotropin-freisetzungshormon-rezeptors
US6939883B2 (en) 2001-08-02 2005-09-06 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
AU2002324586B2 (en) 2001-08-02 2008-04-24 Neurocrine Biosciences, Inc. 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
WO2003011870A1 (en) * 2001-08-02 2003-02-13 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists
US7569570B2 (en) * 2002-01-30 2009-08-04 Takeda Pharmaceutical Company Limited Thienopyrimidines, process for preparing the same and use thereof
EP1495768A4 (de) 2002-04-12 2007-12-05 Takeda Pharmaceutical Mittel zur prävention/behandlung von hitzewallungen
JP2006508050A (ja) * 2002-08-21 2006-03-09 アストラゼネカ アクチボラグ ゴナドトロピン放出ホルモンのアンタゴニストとしてのチエノピロール化合物
EP1591446B1 (de) 2003-01-29 2013-03-06 Takeda Pharmaceutical Company Limited Thienopyrimidinverbindungen und deren Verwendung
GB0307777D0 (en) 2003-04-04 2003-05-07 Medical Res Council Conjugate compounds
US20060083017A1 (en) * 2004-10-18 2006-04-20 Bwt Propety, Inc. Solid-state lighting apparatus for navigational aids
KR20080041662A (ko) 2005-07-22 2008-05-13 다케다 야쿠힌 고교 가부시키가이샤 조기 배란 예방제
EP2329823A4 (de) 2008-09-03 2013-04-03 Takeda Pharmaceutical Verfahren zur erhöhung der absorptionsfähigkeit eines präparats sowie präparat mit erhöhter absorptionsfähigkeit
MX357841B (es) * 2012-02-28 2018-07-26 Tiumbio Co Ltd Antagonistas de los receptores de la hormona liberadora de gonadotropina, método para la preparación de éstos y composición farmacéutica que los contienen.
PL2900675T3 (pl) 2012-09-28 2019-08-30 Takeda Pharmaceutical Company Limited Sposób wytwarzania pochodnej tienopirymidyny
CA2978223A1 (en) * 2015-02-26 2016-09-01 Takeda Pharmaceutical Company Limited Formulations of n-(4-(1-(2,6-difluorobenzyl)-5-((dimethyl amino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-n'-methoxyurea
EP3518933B2 (de) 2016-09-30 2025-02-26 Sumitomo Pharma Switzerland GmbH Verfahren zur behandlung von gebärmuttermyomen und endometriose
CN110248661A (zh) 2016-09-30 2019-09-17 梦欧文科学有限责任公司 前列腺癌的治疗
KR101973074B1 (ko) 2018-11-30 2019-04-26 주식회사 티움바이오 퓨로피리미딘 화합물의 염 및 결정형, 및 이를 포함하는 약학적 조성물
CN111943960B (zh) * 2019-07-29 2022-02-15 广东东阳光药业有限公司 取代的嘧啶二酮类化合物及其用途
JP2022551316A (ja) 2019-10-10 2022-12-08 ミオバント サイエンシズ ゲーエムベーハー N-(4-(1-(2,6-ジフルオロベンジル)-5-((ジメチルアミノ)メチル)-3-(6-メトキシ-3-ピリダジニル)-2,4-ジオキソ-1,2,3,4-テトラヒドロチエノ[2,3-d]ピリミジン-6-イル)フェニル)-N’-メトキシ尿素の結晶形
CN111574534B (zh) * 2020-05-25 2021-06-04 东莞市东阳光新药研发有限公司 苯基取代的噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮类化合物及其用途
BR112022023937A2 (pt) 2020-05-29 2022-12-27 Myovant Sciences Gmbh Formas de dosagem oral sólidas de combinação de antagonistas do hormônio liberador de gonadotropina
CN111925379B (zh) * 2020-07-31 2022-02-15 广东东阳光药业有限公司 含氮杂芳基取代的嘧啶二酮类化合物及其用途
CN111909168B (zh) * 2020-07-31 2022-02-01 广东东阳光药业有限公司 含氮杂环基取代的嘧啶二酮类化合物及其用途
CN112047957B (zh) * 2020-09-09 2022-02-01 广东东阳光药业有限公司 取代的嘧啶二酮类化合物及其用途
CN113754679B (zh) * 2020-09-09 2023-04-07 广东东阳光药业有限公司 取代的嘧啶二酮类化合物及其用途
CN113563303B (zh) * 2020-12-30 2022-04-12 上海博志研新药物技术有限公司 瑞卢戈利中间体及其制备方法
CN115260211B (zh) * 2021-04-29 2024-02-06 长春金赛药业有限责任公司 含噻吩稠环类衍生物、药物组合物及其制备方法和应用
CN113717149A (zh) * 2021-09-29 2021-11-30 成都伊诺达博医药科技有限公司 一种瑞卢戈利关键中间体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW449600B (en) * 1994-04-19 2001-08-11 Takeda Chemical Industries Ltd Condensed-ring thiophene derivatives, their production and use
UY23948A1 (es) * 1995-02-08 2001-10-25 Takeda Chemical Industries Ltd Derivados de anillos condensados de tiofeno su producción y uso.
US5627786A (en) * 1995-02-10 1997-05-06 Micron Quantum Devices, Inc. Parallel processing redundancy scheme for faster access times and lower die area
WO1996028405A1 (fr) * 1995-03-10 1996-09-19 Nitto Chemical Industry Co., Ltd. Procede de production de derives de 1,2-ethanediol

Also Published As

Publication number Publication date
HUP0200550A3 (en) 2004-07-28
ES2212992T3 (es) 2004-08-16
JP3240293B2 (ja) 2001-12-17
KR20010090430A (ko) 2001-10-18
NO20014603D0 (no) 2001-09-21
DK1163244T3 (da) 2004-07-12
CA2368108C (en) 2009-12-22
CN1349536A (zh) 2002-05-15
PT1163244E (pt) 2004-07-30
ID30393A (id) 2001-11-29
OA11920A (en) 2006-04-12
EP1163244A1 (de) 2001-12-19
SK13552001A3 (sk) 2002-03-05
KR100370981B1 (ko) 2003-02-06
AU764019B2 (en) 2003-08-07
CA2368108A1 (en) 2000-09-28
IL145549A (en) 2005-11-20
HUP0200550A2 (en) 2002-06-29
WO2000056739A1 (en) 2000-09-28
HK1042495A1 (en) 2002-08-16
CZ294747B6 (cs) 2005-03-16
TWI225863B (en) 2005-01-01
AU3326200A (en) 2000-10-09
NZ514737A (en) 2003-10-31
AR023152A1 (es) 2002-09-04
NO20014603L (no) 2001-11-26
HK1042495B (en) 2004-10-08
IL145549A0 (en) 2002-06-30
JP2001278884A (ja) 2001-10-10
MXPA01009566A (es) 2002-05-14
US6340686B1 (en) 2002-01-22
KR20010015920A (ko) 2001-02-26
KR100533483B1 (ko) 2005-12-05
DE60008862D1 (de) 2004-04-15
PL351202A1 (en) 2003-03-24
BR0009297A (pt) 2001-12-18
EP1163244B1 (de) 2004-03-10
MY124726A (en) 2006-06-30
DE60008862T2 (de) 2005-01-27
CZ20013419A3 (cs) 2002-02-13

Similar Documents

Publication Publication Date Title
ATE261449T1 (de) Thienopyrimidin verbindungen, ihre herstellung und verwendung
DE69922986D1 (de) Substituierte phenylderivate, ihre herstellung und verwendung
DE69916828D1 (de) Pyrazoline, ihre herstellung und verwendung als medikamente
ATE339440T1 (de) Entzündungshemmende verbindungen und ihre verwendung
DE10084441T1 (de) Koalinton-Pigmente, ihre Herstellung und Verwendung
DE60111734D1 (de) [1,4']-bipiperidin verbindungen
DE69928140D1 (de) Antipicornavirale Verbindungen, deren Herstellung und Verwendung
DE60001307D1 (de) Pyridopyranoazepinderivate, ihre herstellung und therapeutische verwendung
DE59905572D1 (de) Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
DE60045402D1 (de) Silylalkylplatin (IV) Verbindungen und deren Herstellung
DE59802590D1 (de) Cyclische Cedren-Acetale, ihre Herstellung und ihre Verwendung
DE60103054D1 (de) Phenyloxazol-1,4-diazabicyclo[3.2.2]nonanderivate, ihre herstellung und ihre therapeutische verwendung
DE50002417D1 (de) 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung
ATE533768T1 (de) Imidazol-derivate, ihre herstellung und ihre verwendung
DE60005690D1 (de) Titanverbindungen, deren herstellung und verwendung
ATE396994T1 (de) 3-phenylpyridoindolderivate, ihre herstellung und verwendung
ATE212346T1 (de) 3-substituierte tetrahydropyridopyrimidinon- derivate, ihre herstellung und verwendung
DE69723463D1 (de) Cyclische organoselenderivate, ihre herstellung und verwendung
DE60144456D1 (de) DibenzoÄb,fÜazepin-Derivate und ihre Herstellung
ATE249451T1 (de) Benzofuranderivate, ihre herstellung und verwendung
DE59906907D1 (de) Phosphororganische verbindungen und ihre verwendung
DK1164845T3 (da) Landbrugskemisk sammensætning
DE59902692D1 (de) Phosphororganische verbindungen und ihre verwendung
ATE236905T1 (de) 4-oxo-3,5-dihydro-4h-pyridazino(4,5-b)indol-1- carboxamid-derivate, ihre herstellung und therapeutische verwendung
DE69824385D1 (de) Polymerzusammensetzungen, Ihre Herstellung und ihre Verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1163244

Country of ref document: EP

REN Ceased due to non-payment of the annual fee